| Ms Eleanor Holston Ham, MS, OTRL | |
|
740 E Laurel Rd, London, KY 40741-8601 | |
| (606) 877-3950 | |
| Not Available |
| Full Name | Ms Eleanor Holston Ham |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 740 E Laurel Rd, London, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003037847 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 277279 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Eleanor Holston Ham, MS, OTRL 15 Executive Est, London, KY 40744-7894 Ph: (606) 224-0353 | Ms Eleanor Holston Ham, MS, OTRL 740 E Laurel Rd, London, KY 40741-8601 Ph: (606) 877-3950 |
News Archive
In just two weeks from the time the first patient virus samples were made available, Singapore scientists report an evolutionary analysis of a critical protein produced by the 2009 H1N1 influenza A virus strain.
Inherited mutations in voltage-gated sodium channels (Navs) are associated with many different human diseases, including genetic forms of epilepsy and chronic pain. Theodore Cummins and colleagues, at Indiana University School of Medicine, Indianapolis, have now determined the functional consequence of three such mutations.
In a study that included nearly 3,000 adults from Denmark, a diagnosis of meningococcal, pneumococcal, or Haemophilus influenzae meningitis in childhood was associated with lower educational achievement and economic self-sufficiency in adult life, according to a study in the April 24 issue of JAMA.
Researchers at Case Western Reserve School of Medicine have discovered a technique that directly converts skin cells to the type of brain cells destroyed in patients with multiple sclerosis, cerebral palsy and other so-called myelin disorders.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced initiation of patient enrollment in the second Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in hemodialysis patients with secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease.
› Verified 8 days ago
Natalie Johnstone, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 London Mountain View Dr, Suite 400, London, KY 40741 Phone: 606-330-0513 | |
Ms. Dena Kay Partin, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 202 West 7th Street, London, KY 40741 Phone: 606-864-7316 Fax: 606-878-0590 | |
Megan Mefford, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 181 Old Whitley Rd, London, KY 40744 Phone: 606-330-0223 | |
Mrs. Lindsay Allen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 740 E Laurel Rd, London, KY 40741 Phone: 606-877-3950 Fax: 606-877-3956 | |
Melanie Sams, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 181 Old Whitley Rd, London, KY 40744 Phone: 606-330-0223 | |
Paige Whitaker Oliver, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 392 Hoskins Cemetery Rd, London, KY 40741 Phone: 606-864-2788 Fax: 606-864-2788 |